Regular Article
c-erbB-2 Gene Product Associates with Catenins in Human Cancer Cells

https://doi.org/10.1006/bbrc.1994.2631Get rights and content

Abstract

Phosphorylation of β-catenin, an intracytoplasmic cadherin-binding protein, causes disruption of the cadherin-mediated cell adhesion system in cancer cells. A 185-kDa phosphorylated protein, identified as the c-erbB-2 gene product, was co-immunoprecipitated with the E-cadherin-catenin complex. Association of the c-erbB-2 gene product with the cadherin-catenin complex was proven to be mediated through β-catenin and plakoglobin using an in vitro protein-protein precipitation system. These results indicate that the c-erbB-2 gene product associates with catenins and may regulate the cell adhesion and invasive growth of cancer.

References (0)

Cited by (143)

  • Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis

    2018, Experimental Cell Research
    Citation Excerpt :

    The identified c-erbB-2 gene product is an oncogene product (homologous to EGFR) that provides the first evidence of cell-cell adhesion molecules interaction with oncogene product (Fig. 8 [51–55]. Tyrosine phosphorylation of catenins was found to be initiated by epidermal growth factor (EGF), which is known to be induced scattering of cancer cell lines, and a direct interaction between EGFRs and β-catenin [56–59]. Cadherin is a vital player in cancer phenotypes and continuing the efforts to understand the mode of function in context to tumor invasion and metastasis.

  • Clostridium difficile toxin B recombinant protein inhibits tumor growth and induces apoptosis through inhibiting Bcl-2 expression, triggering inflammatory responses and activating C-erbB-2 and Cox-2 expression in breast cancer mouse model

    2018, Biomedicine and Pharmacotherapy
    Citation Excerpt :

    For the in vivo experiments, the rcdtB inhibited the tumor growth and decreased the tumor volume. The previous studies [24,25] reported that C-erbB-2 confers an unfavorable prognosis to breast cancer patients, including increasing the cell mobility, disruption of tumor-cell adhesion, enhancing proliferation and inhibiting apoptosis. Our study showed that the C-erbB-2 expression was significantly decreased when undergoing the rcdtB treatment.

  • Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer

    2011, Annals of Thoracic Surgery
    Citation Excerpt :

    Also, CA IX is associated with upregulation of epidermal growth factor receptor, c-erbB-2, and mucin 1 [19]. All three proteins disrupt cell–cell adhesion by degrading the catenin–cadherin complex, or the integrin-mediated cell adhesion system [20]. The c-erbB2 proteins are well known to mediate cellular motility and migration, and mucin 1is involved in endothelial adhesion and cancer metastasis [21].

  • A Laboratory Guide to the Tight Junction

    2020, A Laboratory Guide to the Tight Junction
View all citing articles on Scopus
View full text